BOOST PHYSICAL PERFORMANCE

by HEALTHCARE

Physical activity and correct nutrition help lay the foundations for optimizing health.

Regular exercise not only helps prevent the onset of degenerative diseases, but can also improve disease variables (18).

For example, diseases comorbid to COVID19, such as hypertension, obesity, diabetes and chronic lung diseases, are associated with admissions to intensive care and with more severe courses of the disease.

These conditions in turn are very frequently related to less regular physical activity (14).

At the same time, proper nutrition is an essential requirement for effective improvement of exercise, conditioning, recovery from fatigue after physical activity, and injury prevention (1).

Recently, food components with physiological actions have been called “functional foods” and the effects of such foods have been scientifically investigated.

Enikia © contains functional foods in its formula such as glycine, an excitatory neurotransmitter of the nervous system.

Glycine is important in obtaining strength in the muscles, supporting the generation of muscle mass through protein synthesis, collagen, the production of growth hormone and in the production of energy in our body.

Additionally, glycine supplementation has been shown to reduce lactate production during exercise, resulting in less muscle soreness after intense exercise (5).

Enikia © also contains arginine, which contributes positively to physical activity through the synthesis of nitric oxide and creatine to increase physical performance and muscle strength (1).

During intense physical exercise, oxidative processes and reactive oxygen and nitrogen species can increase, which requires the existence of an extra stimulus for antioxidant defenses, for this, Enikia® contains one of the most powerful natural antioxidants, which is resveratrol, which, accompanied by the detoxifying amino acid called cysteine, helps protect the body during exercise against the potential damage of increased oxidative stress (13, 19, 22).

Finally, Enikia © has shown in research that the patented formula can reduce the formation of visceral fat in diabetes models, also controlling glucose levels, so it could support health improvement processes through changes in habits and exercise in healthy people and especially in people who are being treated for diseases such as diabetes and obesity (1).

Equilibrio y vitalidad

BALANCE AND VITALITY

Health is described in many ways, for example, it is considered as a dynamic condition of resilience to stressors and the...

Juntos en tu recuperación

TOGETHER IN YOUR RECOVERY

When people go through illness and do not eat properly, they tend to reduce their daily activities and use fat and muscle reserves for energy...

References

    1. Aoi W, Naito Y, Yoshikawa T. Exercise and functional foods. Nutr J. 2006 Jun 5;5:15. doi: 10.1186/1475-2891-5-15. PMID: 16749944; PMCID: PMC1526446.
    2. Astudillo de la Vega, H. (2016). Patent: Combination of metabolic bio-energetic and nutra-epigentic regulators, nutraceutical compounds in conventional and nanotechnologies combination to revert and prevent the chronic damage accelerated cellular senescence produced by diabetes and other (Patent No. Application US433 20160354331-A1). OA19128A – Combination of metabolic regulators and nutraceuticals for the prevention of chronic damage from diabetes. – Google Patents. https://patents.google.com/patent/OA19128A/en?q=(dela+vega)&inventor=astudillo&assignee=horacio&oq=horacio+astudillo+dela+vega. Accessed: 2023-08-08
    3. Baur, J. A. et al., (2006) . Resveratrol improves health and survival of mice on a high calorie diet. Nature, 444 (7117): 337-342.
    4. Beher, D., Wu, J., Cumine, S., Kim, K. W. , Lu, S. C., Atangan, L., Wang, M. (2009) . Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des., 74 (6): 619-624. doi: 10.1111/j.1747-0285.2009.00901.x.PMID 19843076.
    5. Buford, B. N., & Koch, A. J. (2004). Glycine-arginine-α-ketoisocaproic acid improves performance of repeated cycling sprints. Medicine & Science in Sports & Exercise, 36(4), 583-587.
    6. , Kopp, B., Bauer, R., Stuppner, H., Dirsch, V. M. , Atanasov, A. G. (2014). Naturel product agonists of peroxisome proliferator-activated receptor gamma (PPARy): a review. Biochem Pharmacol 92 (1) : 73-89. doi: 10.1016/j.bcp.2014.07.018. PMC 4212005. PMID 25083916.
    7. Di Renzo, Laura, Paola Gualtieri, and Antonino De Lorenzo. «Diet, Nutrition and Chronic Degenerative Diseases» Nutrients13, no. 4: 1372. https://doi.org/10.3390/nu13041372
    8. Di Renzo, Laura, Paola Gualtieri, Lorenzo Romano, Giulia Marrone, Annalisa Noce, Alberto Pujia, Marco Alfonso Perrone, Vincenzo Aiello, Carmela Colica, and Antonino De Lorenzo. «Role of Personalized Nutrition in Chronic-Degenerative Diseases» Nutrients11, no. 8: 1707. https://doi.org/10.3390/nu11081707.
    9. Do, G. M. et al., (2008). Long-term effects of resveratrol supplémentation on suppression of atherogenic lésion formation and cholestérol synthesis in apo Edeficient mice. Biochem. Biophys. Res. Commun., 374(1): 55-59.
    10. Dodds W. Disease Now and Potential Future Pandemics. The World’s Worst Problems. 2019 Dec 3:31–44. doi: 10.1007/978-3-030-30410-2_4. PMCID: PMC7120200.
    11. Duffy, S. J., Vita, J. A. (2003). Effects of phenolics on vascular endothélial function. Current Opinion in Lipidology, 14 (1) : 21-27. doi:10.1097/01.mol.0000052857. 26236.f2, PMID 12544657.
    12. Jayanthi P, Joshua E, Ranganathan K. Ageing and its implications. J Oral Maxillofac Pathol. 2010 Jul;14(2):48-51. doi: 10.4103/0973-029X.72500. PMID: 21731262; PMCID: PMC3125059.
    13. Kerksick CM, Wilborn CD, Roberts MD, Smith-Ryan A, Kleiner SM, Jäger R, Collins R, Cooke M, Davis JN, Galvan E, Greenwood M, Lowery LM, Wildman R, Antonio J, Kreider RB. ISSN exercise & sports nutrition review update: research & recommendations. J Int Soc Sports Nutr. 2018 Aug 1;15(1):38. doi: 10.1186/s12970-018-0242-y. PMID: 30068354; PMCID: PMC6090881.
    14. Klöting, N.; Schwarzer, M.; Heyne, E.; Ceglarek, U.; Hoffmann, A.; Krohn, K.; Doenst, T.; Blüher, M. Intrinsic Exercise Capacity Affects Glycine and Angiotensin-Converting Enzyme 2 (ACE2) Levels in Sedentary and Exercise Trained Rats. Metabolites 2022, 12, 548. https://doi.org/10.3390/metabo12060548
    15. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., Auwerx, J. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-lalpha. Cell 127 (6) : 1109-1122. doi:10.1016/j.cell.2006.11.013. PMID 17112576.
    16. Lodder, R. A., Cassis L. A. (2016). D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof. Patent US 2015/9,060,962, Jun. 23, 2015.
    17. Marti-Centelles, R., Falomir, E., Murga, J., Carda, M., Marco, J. A. (2015). Inhibitory effect of cytotoxic stilbenes related to resveratrol on the expression of the VEGF, hTERT and c-Myc genes. Eur J Med Chem. 103: 488-496.
    18. Meuffels Frederike Maria, Isenmann Eduard, Strube Malte, Lesch Alessio, Oberste Max, Brinkmann Christian. xercise Interventions Combined With Dietary Supplements in Type 2 Diabetes Mellitus Patients—A Systematic Review of Relevant Health Outcomes. Frontiers in Nutrition;VOLUME 9;2022. https://www.frontiersin.org/articles/10.3389/fnut.2022.817724. doi:10.3389/fnut.2022.817724
    19. Mostafa Koohkan, Majid Vahidian-Rezazadeh, Reza Delavar, The Effect of Short-term Administration of High-dose Vitamins E and C on Serum Creatine Kinase and Myoglobin in the Resting Phase of Elite Sanda Athletes: A Randomized Trial, Asian Journal of Sports Medicine, 10.5812/asjsm-134047, 14, 2, (2023).
    20. Oleribe OO, Ukwedeh O, Burstow NJ, Gomaa AI, Sonderup MW, Cook N, Waked I, Spearman W, Taylor-Robinson SD. Health: redefined. Pan Afr Med J. 2018 Aug 24;30:292. doi: 10.11604/pamj.2018.30.292.15436. PMID: 30637076; PMCID: PMC6320447.
    21. Romero, T. (2016). Methods and materials for reducing multiple risk factors associated with the metabolic syndrome. Patent US 2016/9,278,104, Mar. 8, 2016. Vanhaecke, P., Persoone, G., Claus, C., Sorgeloos, P. (1981). Proposai for a short-term toxicity test with Artemia nauplii. Ecotoxicol Environ Saf. 5: 382-387.
    22. Rothschild JA, Kilding AE, Plews DJ. What Should I Eat before Exercise? Pre-Exercise Nutrition and the Response to Endurance Exercise: Current Prospective and Future Directions. Nutrients. 2020 Nov 12;12(11):3473. doi: 10.3390/nu12113473. PMID: 33198277; PMCID: PMC7696145.
    23. SIRT1 negatively régulâtes the mammalian target of rapamycin. PLoS ONE 5 (2): e9199. Bibcode:2010PLoSO. 5.9199G. doi: 10.1371/journal.pone.0009199.PMC 2821410.PMID 20169165.
    24. Sirtuins: novel targets for metabolic disease in drug development. Biochem. Biophys. Res. Commun. 373(3): 341-344.
    25. Varfolomeev, S. D. , Gurevich, K. G. (2001) . Enzyme active sites: bioinformatics, architecture, and mechanisms of action. Russian Chemical Bulletin. 50 (10): 1709-1717.
    26. Wu, G. A. B., Meininger, C. J., Knabe, D. A., Baze, F. W. A., Rhoads, J. M. (2000) Arginine nutrition in development, health and disease. Current Opinion in Clinical Nutrition & Metabolic Care. 3 (1) : 59-66.
    en_US